Marijana Virijevic Selected Research

Acute Promyelocytic Leukemia

2/2020

The influence of Wilms' tumor 1 gene expression level on prognosis and risk stratification of acute promyelocytic leukemia patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marijana Virijevic Research Topics

Disease

3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2020 - 06/2012
2	COVID-19 01/2022 - 10/2021
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021 - 04/2015
1	Hemorrhage 01/2022
1	Infections 01/2022
1	Pulmonary Embolism 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Bone Marrow Failure Disorders 10/2021
1	Hemolysis 10/2021
1	Acute Promyelocytic Leukemia 02/2020
1	Wilms Tumor (Wilm's Tumor) 02/2020
1	Neoplasms (Cancer) 01/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	Thrombosis (Thrombus) 04/2015
1	Paraproteinemias (Monoclonal Gammopathy) 01/2013

Drug/Important Bio-Agent (IBA)

2	fibrin fragment D (D-dimer)IBA 01/2022 - 04/2015
1	Thrombopoietin ReceptorsIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Inosine Triphosphate (ITP)IBA 01/2022
1	eculizumab FDA Link 10/2021
1	Complement System Proteins (Complement)IBA 10/2021
1	Warfarin (Coumadin)FDA LinkGeneric 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 04/2015
1	ParaproteinsIBA 01/2013
1	CD56 AntigenIBA 09/2012

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2020
1	Drug Therapy (Chemotherapy) 06/2012